Medicare GLP-1 Bridge
Centers for Medicare & Medicaid Services publishes this at $50 a month. Medicare route — separate from the savings card, which excludes Medicare.
Last updated 2026-08-24 — the last time this offer was read from Centers for Medicare & Medicaid Services's own page
What does the Medicare GLP-1 Bridge actually get you?
Centers for Medicare & Medicaid Services publishes the Medicare GLP-1 Bridge at $50 a month It exists because the ordinary savings card cannot touch a Medicare beneficiary at all — federal anti-kickback rules bar a manufacturer from subsidising a copay inside a federal programme — so this is a separate route rather than a discount on the usual one. The condition attached: The $50 does not count toward your Part D deductible or the out-of-pocket maximum, because the demonstration sits outside Part D coverage rather than inside it. It carries a published end date of 2027-12-31, after which any site still quoting it is quoting a price that no longer exists. Without any programme, halfrx records Zepbound at $449 a month at the maintenance dose, verified against the seller's own page on 2026-08-19. 2 other programmes exist for Zepbound, and they answer different situations rather than competing on price.
The terms, as published
- Price
- $50 a month
- Who for
- Part D beneficiaries whose prescriber submits a prior authorisation attesting the drug treats obesity, and who meet one of the demonstration's BMI and clinical categories. Covers all formulations of Foundayo and Wegovy, and the KwikPen formulation of Zepbound only.
- The catch
- The $50 does not count toward your Part D deductible or the out-of-pocket maximum, because the demonstration sits outside Part D coverage rather than inside it. It is also time-limited: a demonstration under Section 402 authority, not a benefit.
- Ends
- 2027-12-31
- Source
- www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridgeread 2026-08-24
If your plan already covers Zepbound
A self-pay price is not the obvious choice here. Paying cash means the spend does not count towards a deductible or an out-of-pocket maximum, so a covered patient can end a year worse off having bought the drug outside the plan. Compare it against the copay route before choosing. Zepbound savings card is the copay card for Zepbound.
If it does not cover Zepbound
This is the case the Medicare GLP-1 Bridge answers. No coverage is needed and no plan has to approve anything, so nothing here turns on a prior authorisation. Getting the plan to cover it is the other route, and it is worth trying before settling for a cash price.
What Zepbound costs with no programme at all
halfrx records $449 a month at the maintenance dose, read from the seller's own page on 2026-08-19. That is the figure the Medicare GLP-1 Bridge has to beat to be worth the conditions attached to it.
A pharmacy acquires Zepbound for about $1,051 a month under the federal NADAC survey, effective 2026-08-18. Where a sponsor's cash price sits below that, it is not a discount off the pharmacy channel — it is a different market with no intermediary to pay.
A first year is not twelve times the advertised month. Walking the titration ladder at each step's published price gives $5,637 rather than the $5,388 the monthly figure implies. Lilly defines a month as 28 days, so a year is 13 fills rather than 12. The full Zepbound ladder prices every step.
The other 2 programmes for Zepbound
- Zepbound Journey Program
$449 a month at 7.5 mg and above — self-pay price — the figure with insurance out of the picture.
- Zepbound savings card
As little as $25 for up to a 3-month prescription — copay card — needs insurance that already covers the drug.
Questions about the Medicare GLP-1 Bridge
- Do I need insurance to use the Medicare GLP-1 Bridge?
- You need Medicare rather than commercial insurance. This route exists precisely because the ordinary savings card is barred from federal beneficiaries under anti-kickback rules, so the two are alternatives, not a stack.
- What is the catch on the Medicare GLP-1 Bridge?
- The $50 does not count toward your Part D deductible or the out-of-pocket maximum, because the demonstration sits outside Part D coverage rather than inside it. It is also time-limited: a demonstration under Section 402 authority, not a benefit.
- When does the Medicare GLP-1 Bridge end?
- Centers for Medicare & Medicaid Services publishes an end date of 2027-12-31, which is 492 days from the last time this page rebuilt. Any site still quoting the price after that date is quoting an offer that no longer exists.
halfrx is not affiliated with Centers for Medicare & Medicaid Services and is paid nothing for listing this. Every figure is read from the sponsor's own page on the date shown. Information only, not medical advice.